Try our beta test site

Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by M.D. Anderson Cancer Center
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01701986
First received: October 3, 2012
Last updated: February 3, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 1, 2018
  Estimated Primary Completion Date: October 1, 2018 (Final data collection date for primary outcome measure)